NCT03547973 2026-03-16
TROPHY U-01
Gilead Sciences
Phase 2 Recruiting
Clinical Trials
6 trialsNCT04995419 2025-10-07
A Study to Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor Therapy
Astellas Pharma Inc
Phase 2 Completed
NCT05390645 2024-09-26
MANHATTAN
Ectin Research AB
Phase 1/2 Withdrawn
NCT02826564 2024-07-17
Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer
University Hospital, Ghent
Phase 1 Completed
NCT03451331 2024-05-16
Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer
Hoosier Cancer Research Network
Phase 2 Completed
NCT03448718 2023-11-22
Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations
Hoosier Cancer Research Network
Phase 2 Completed